Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPD

GlaxoSmithKline · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
chronic-obstructivepulmonary-disease
pulmonary disease, chronic obstructive, trelegy ellipta, single inhaler, fluticasone furoate, umeclidinium bromide, vilanterol, ff/umec/vi, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 898414
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.